Related references
Note: Only part of the references are listed.Alzheimer's disease and type 2 diabetes mellitus: A systematic review of proteomic studies
Jessica Diniz Pereira et al.
JOURNAL OF NEUROCHEMISTRY (2021)
Platelet biomarkers for a descending cognitive function: A proteomic approach
Haitao Yu et al.
AGING CELL (2021)
Harnessing the Physiological Functions of Cellular Prion Protein in the Kidneys: Applications for Treating Renal Diseases
Sungtae Yoon et al.
BIOMOLECULES (2021)
Caveolin: A New Link Between Diabetes and AD
Andrei Surguchov
CELLULAR AND MOLECULAR NEUROBIOLOGY (2020)
Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs
A. B. Niculescu et al.
MOLECULAR PSYCHIATRY (2020)
Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease
Hong Wang et al.
MOLECULAR NEURODEGENERATION (2020)
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Jakob M. Bader et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19
Ting Shu et al.
IMMUNITY (2020)
Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau
Nabil F. Darwich et al.
SCIENCE (2020)
Corticotropin releasing factor-binding protein (CRF-BP) as a potential new therapeutic target in Alzheimer's disease and stress disorders
Dorien Vandael et al.
TRANSLATIONAL PSYCHIATRY (2019)
Diabetic ketoacidosis further increases risk of Alzheimer's disease in patients with type 2 diabetes
Yu-Li Chen et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential
Ana Marta de Matos et al.
MEDICINAL RESEARCH REVIEWS (2018)
Mitochondrial complex III Rieske Fe-S protein processing and assembly
Erika Fernandez-Vizarra et al.
CELL CYCLE (2018)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
Direct pharmacological Akt activation rescues Alzheimer's disease like memory impairments and aberrant synaptic plasticity
Jee Hyun yi et al.
NEUROPHARMACOLOGY (2018)
CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer's Disease
Yang-Ping Shentu et al.
CELL REPORTS (2018)
natureOUTLOOK ALZHEIMER'S DISEASE
Richard Hodson
NATURE (2018)
The diagnostic value of FDG and amyloid PET in Alzheimer's disease-A systematic review
Louise Rice et al.
EUROPEAN JOURNAL OF RADIOLOGY (2017)
Conditional Deletion of Prnp Rescues Behavioral and Synaptic Deficits after Disease Onset in Transgenic Alzheimer's Disease
Santiago V. Salazar et al.
JOURNAL OF NEUROSCIENCE (2017)
Lack of association of mortalin (HSPA9) and othermitochondria-related genes with risk of Parkinson's and Alzheimer's diseases
Sun Ju Chung et al.
NEUROBIOLOGY OF AGING (2017)
The role of CIP2A in cancer: A review and update
Saiedeh Razi Soofiyani et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Bengt Winblad et al.
LANCET NEUROLOGY (2016)
Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study
Zhi-Peng Xu et al.
EBIOMEDICINE (2016)
Type 2 diabetes as a risk factor for cognitive impairment: current insights
Hiroyuki Umegaki
CLINICAL INTERVENTIONS IN AGING (2014)
Prolidase function in proline metabolism and its medical and biotechnological applications
R. L. Kitchener et al.
JOURNAL OF APPLIED MICROBIOLOGY (2012)
Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system
Hemmo Meyer et al.
NATURE CELL BIOLOGY (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?
Kawser Akter et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
A Systematic Analysis of Eluted Fraction of Plasma Post Immunoaffinity Depletion: Implications in Biomarker Discovery
Amit Kumar Yadav et al.
PLOS ONE (2011)
The biochemical basis of hereditary fructose intolerance
Nadia Bouteldja et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein
David A. Gimbel et al.
JOURNAL OF NEUROSCIENCE (2010)
The clinical use of structural MRI in Alzheimer disease
Giovanni B. Frisoni et al.
NATURE REVIEWS NEUROLOGY (2010)
Mild Cognitive Impairment Ten Years Later
Ronald C. Petersen et al.
ARCHIVES OF NEUROLOGY (2009)
Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease
Sherryline Jogie-Brahim et al.
ENDOCRINE REVIEWS (2009)
Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells
Toshiyuki Nakamura et al.
MOLECULAR NEURODEGENERATION (2009)
Universal sample preparation method for proteome analysis
Jacek R. Wisniewski et al.
NATURE METHODS (2009)
Roles of VCP in human neurodegenerative disorders
Akira Kakizuka
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation
Florian Plattner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
RC Petersen et al.
NEUROLOGY (2001)
Share Paper
